GROWTH HORMONE-PRODUCING PITUITARY TUMOUR

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting GROWTH HORMONE-PRODUCING PITUITARY TUMOUR:

# Drug Count
0 PEGVISOMANT 18
1 LEVOTHYROXINE SODIUM 17
2 OCTREOTIDE ACETATE 16
3 CARBAMAZEPINE 15
4 MELATONIN 15
5 PRIMIDONE 15
6 PROPRANOLOL HYDROCHLORIDE 15
7 RISPERIDONE 15
8 ATOMOXETINE HYDROCHLORIDE 14
9 HYDROCORTISONE 13
See all common drugs associated with GROWTH HORMONE-PRODUCING PITUITARY TUMOUR

GROWTH HORMONE-PRODUCING PITUITARY TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGVISOMANT 18 0.0044
1 PRIMIDONE 15 0.0015
2 POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE 1 0.0008
3 ATOMOXETINE HYDROCHLORIDE 14 0.0006
4 TESTOSTERONE 13 0.0005
5 OCTREOTIDE ACETATE 16 0.0005
6 CABERGOLINE 2 0.0004
7 MELATONIN 15 0.0003
8 CARBAMAZEPINE 15 0.0002
9 PROPRANOLOL HYDROCHLORIDE 15 0.0002
See all drugs enriched for association with GROWTH HORMONE-PRODUCING PITUITARY TUMOUR

GROWTH HORMONE-PRODUCING PITUITARY TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Androgen [EPC] 13 0.0005
1 Ergot Derivative [EPC] 2 0.0004
2 Somatostatin Analog [EPC] 1 0.0001
3 Anti-epileptic Agent [EPC] 16 0.0001
4 Mood Stabilizer [EPC] 15 0.0001
5 Atypical Antipsychotic [EPC] 15 0.0000
6 5-alpha Reductase Inhibitor [EPC] 3 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Opioid Agonist [EPC] 6 0.0000
9 Corticosteroid [EPC] 17 0.0000
See all drug classes enriched for association with GROWTH HORMONE-PRODUCING PITUITARY TUMOUR